News tagged with endometrial


Genomics to reshape endometrial cancer treatment

The most in-depth look yet at endometrial cancer shows that adding genomics-based testing to the standard diagnostic workup could change the recommended course of treatment for some women.

Cancer created May 01, 2013 | popularity not rated yet | comments 0 | with audio podcast

Novel AKT pathway inhibitor, ARQ 092, demonstrated safety, effective target inhibition

Researchers have confirmed that the novel oral agent ARQ 092 inhibits the AKT pathway and has a manageable safety profile in patients with a variety of advanced solid tumors, according to phase I data presented at the AACR ...

Cancer created Apr 09, 2013 | popularity not rated yet | comments 0

Genes behind aggressive endometrial cancer found

In a major breakthrough for uterine serous carcinoma (USC)—a chemo-resistant, aggressive form of endometrial cancer, Yale researchers have defined the genetic landscape of USC tumors, findings that point to new treatment ...

Cancer created Jan 28, 2013 | popularity 5 / 5 (1) | comments 0 | with audio podcast

Healthy BMI levels, physical activity linked to endometrial cancer survival

(Medical Xpress)—Higher body mass index (BMI) and physical inactivity are associated with more than a two-fold increase in risk for mortality among women with endometrial cancer, new research by the Yale ...

Cancer created Jan 08, 2013 | popularity not rated yet | comments 0 | with audio podcast

Researchers identify novel genes that may drive rare, aggressive form of uterine cancer

Researchers have identified several genes that are linked to one of the most lethal forms of uterine cancer, serous endometrial cancer. The researchers describe how three of the genes found in the study are ...

Cancer created Oct 28, 2012 | popularity 4.5 / 5 (2) | comments 0 | with audio podcast

Increased colorectal cancer risk for extended family members, younger endometrial cancer patients

Women under age 50 who have been diagnosed with endometrial cancer, and first, second and third degree relatives of patients with colorectal cancer may have an increased risk of developing colorectal cancer (CRC), according ...

Cancer created Oct 22, 2012 | popularity not rated yet | comments 0

Common birth control device may be cost-effective treatment for early endometrial cancer

A common birth control device is effective in treating early-stage endometrial cancer in morbidly obese and high-risk surgery patients, said Georgia Health Sciences University Cancer Center researchers, and ...

Cancer created Oct 16, 2012 | popularity not rated yet | comments 0

Women who give birth after age 30 lower their risk of endometrial cancer

Women who last give birth at age 40 or older have a 44 percent decreased risk of endometrial cancer when compared to women who have their last birth under the age of 25, according to strong evidence in a new, international ...

Cancer created Jul 25, 2012 | popularity not rated yet | comments 0 | with audio podcast

Molecule found that inhibits estrogen, key risk factor for endometrial and breast cancers

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a molecule that inhibits the action of estrogen. This female hormone plays a key role in the growth, maintenance and repair of reproductive ...

Medical research created May 09, 2012 | popularity not rated yet | comments 0 | with audio podcast

Low bone density medications may have protective effect on endometrial cancer

Low bone density medications, such as Fosamax, Boniva and Actonel, may have a protective effect for endometrial cancer, according to a study at Henry Ford Hospital.

Cancer created Mar 21, 2012 | popularity not rated yet | comments 0

Significant weight gain in adulthood increased risk for endometrial cancer

Postmenopausal women who gained weight during adulthood had an increased risk for endometrial cancer compared with women who maintained a stable weight, according to data from the American Cancer Society's Cancer Prevention ...

Cancer created Oct 24, 2011 | popularity not rated yet | comments 0

TGen licenses first drug for patient use in clinical care

The Translational Genomics Research Institute (TGen) has licensed its first drug, a unique compound that targets cancer tumors by modifying the actions of proteins.

Medications created May 04, 2011 | popularity not rated yet | comments 0